Date of Grant: _______________ STOCK OPTION AGREEMENT THIS AGREEMENT is made by and between Dragon Pharmaceutical, Inc., a Florida corporation (the "Company") and ______________("Optionee"), as of _____________, 2001. In consideration of the mutual...Stock Option Agreement • February 16th, 2001 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
Exhibit 99.2 JOINT FILING AGREEMENT The undersigned hereby agree to jointly prepare and file with regulatory authorities a Schedule 13D reporting each of the undersigned's ownership of shares of common stock of Dragon Pharmaceutical, Inc., a Florida...Joint Filing Agreement • October 29th, 2003 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.16 SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT (the "Agreement") is dated June 11, 2004 AMONG: DRAGON PHARMACEUTICAL INC., a company incorporated under the laws of the State of Florida, with an office at 1900 - 1055 West Hastings...Share Purchase Agreement • June 21st, 2004 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
EXHIBIT 99.1 SHAREHOLDERS AGREEMENT AMONG CERTAIN SHAREHOLDERS OF DRAGON PHARMACEUTICALS INC.Shareholders Agreement • October 29th, 2003 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
AMONG:Share Exchange Agreement • November 4th, 1999 • Dragon Pharmaceuticals Inc • British Columbia
Date of Grant: May 31 2001 STOCK OPTION AGREEMENT THIS AGREEMENT is made by and between Dragon Pharmaceutical, Inc., a Florida corporation (the "Company") and Kin Foon Tai (Joe) ("Optionee"), is effective as of May 31 2001. In consideration of the...Stock Option Agreement • July 2nd, 2001 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
ACQUISITION AGREEMENT THIS AGREEMENT executed as of October 6, 2000, AMONG: DRAGON PHARMACEUTICALS INC., a company organized and existing under the Laws of the State of Florida, the United States of America, having a principal place of business at...Acquisition Agreement • October 20th, 2000 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
Amendment to the China-Foreign Joint Venture Agreement (the "Agreement") Dated 27 July 1999 BETWEEN: The Nanjing Yiyao Group Company Limited (Party A) AND: Allwin Newtech Ltd. (Party B) Article 19 of the Agreement is hereby amended to read as follows:...Joint Venture Agreement • November 30th, 2000 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.14 PROJECT DEVELOPMENT AGREEMENT THIS AGREEMENT executed as of January 14, 2002. AMONG: DRAGON PHARMACEUTICALS INC., a company organized and existing under the Laws of the State of Florida, the United States of America, having a principal...Development Agreement • April 1st, 2002 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
Exhibit 10.20 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Agreement • March 2nd, 2005 • Dragon Pharmaceutical Inc • Pharmaceutical preparations
Exhibit 10.18 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Collaboration Agreement • March 2nd, 2005 • Dragon Pharmaceutical Inc • Pharmaceutical preparations • British Columbia
SINO-FOREIGN CO-OPERATIVE COMPANY CONTRACT CHAPTER 1 - GENERAL PRINCIPLES AND DEFINITIONS Sanhe City Yanjiao Sinoway Biotech Ltd. (hereinafter referred as "Sinoway") and Allwin Newtech Ltd. of British Virgin Islands (hereinafter referred as "Allwin")...Dragon Pharmaceuticals Inc • November 4th, 1999
Sino-Foreign Joint Venture Contract Part I General Rules and Definitions The Nanjing Medical Group Company Limited (hereafter abbreviated to Party A) and Allwin Newtech Ltd. of the British Virgin Islands (hereafter abbreviated to Party B), in...Dragon Pharmaceuticals Inc • November 4th, 1999 • Jiangsu
Exhibit 10.19 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Agent Agreement THIS...Agent Agreement • March 2nd, 2005 • Dragon Pharmaceutical Inc • Pharmaceutical preparations • Hong Kong
Exhibit 10.23 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Manufacturing...Dragon Pharmaceutical Inc • March 2nd, 2005 • Pharmaceutical preparations
Exhibit 10.21 Portions redacted. * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Dragon Pharmaceutical Inc • March 2nd, 2005 • Pharmaceutical preparations
MARKETING AND LICENSE AGREEMENT THIS AGREEMENT is made as of 9 August 2000, BETWEEN: Allwin Biotrade Ltd., a company having offices at 1200, 543 Granville Street, Vancouver, British Columbia, Canada, ("Allwin") AND: Duopharma (Malaysia) SDN. BHD., a...Marketing and License Agreement • October 20th, 2000 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
EXHIBIT 10.11A Sino-Foreign Joint Venture Contract Part I General Rules and Definitions The Nanjing Medical Group Company Limited (hereafter abbreviated to Party A) and Allwin Newtech Ltd. of the British Virgin Islands (hereafter abbreviated to Party...Joint Venture Agreement • December 26th, 2000 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • Jiangsu
AGREEMENT AND PLAN OF MERGER BY AND AMONG DRAGON PHARMACEUTICAL INC., CHIEF RESPECT LIMITED, DATONG INVESTMENT INC. AND YANLIN HAN Dated as of March 26, 2010Agreement and Plan of Merger • June 23rd, 2010 • Dragon Pharmaceutical Inc • Pharmaceutical preparations • Florida
THIS AGREEMENT AND PLAN OF MERGER, dated as March 26, 2010 (this “Agreement”), is made and entered into by and among Dragon Pharmaceutical Inc., a Florida corporation (the “Company”), Chief Respect Limited, a Hong Kong corporation (“Parent”), Datong Investment Inc., a Florida corporation and a subsidiary of Parent (“MergerSub”), and Mr. Yanlin Han, an individual (“Mr. Han”) solely with respect to Sections 5.06, 7.01(c), 7.08, 8.03(b), 9.03(c) and (d).
SAMPLE)Technical Advisor Agreement • August 3rd, 2000 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
EXHIBIT 10.26 PURCHASE AGREEMENT This Purchase Agreement (this "Agreement") is made by and between DRAGON PHARMACEUTICAL, INC., a Florida corporation ("Dragon") and AS BIOTECH AG in foundation, a Swiss company ("AS Biotech"), effective as of January...Purchase Agreement • April 3rd, 2006 • Dragon Pharmaceutical Inc • Pharmaceutical preparations
COLLABORATION AGREEMENTAgreement • September 9th, 2004 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
THIS AGREEMENT WITNESSES that in consideration of $1 paid and other consideration given, by each party to each other party, the receipt and sufficiency of which each party acknowledges, the parties severally AGREE as follows:
EXHIBIT 10.13 PATENT DEVELOPMENT AGREEMENT THIS AGREEMENT executed as of January 14, 2002. AMONG: DRAGON PHARMACEUTICALS INC., a company organized and existing under the Laws of the State of Florida, the United States of America, having a principal...Patent Development Agreement • April 1st, 2002 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • British Columbia
ASSETS PURCHASE AGREEMENT BETWEEN SHANXI WEIQIDA PHARMACEUTICAL COMPANY LIMITED AND SHANXI QIANYUAN PHARMACEUTICAL COMPANY LIMITED ASSETS PURCHASE AGREEMENTAssets Purchase Agreement • August 14th, 2006 • Dragon Pharmaceutical Inc • Pharmaceutical preparations
Shanxi Weiqida Pharmaceutical Company Limited (hereinafter referred to as “Weiqida”), a wholly foreign owned enterprise, duly organized and validly existing under the laws of the People’s Republic of China (the “PRC”), with its legal address at Datong City Economic and Technology Development Zone, Shanxi Province, the PRC;
DEVELOPMENT AND MANUFACTURING AGREEMENTDevelopment and Manufacturing Agreement • September 9th, 2004 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations
Dragon Pharmaceutical, Inc., a corporation duly incorporated under the laws of the state of Florida, USA, having an office at 1900-1055 West Hastings St., Vancouver, British Colombia, Canada, and duly licensed to do business there.
PURCHASE AND SERVICE AGREEMENT between Shanxi Weiqida Pharmaceutical Co. Ltd. and Shanxi Qianyuan Pharmaceutical Co. Ltd. July 28, 2006 PURCHASE AND SERVICE AGREEMENTPurchase and Service • August 14th, 2006 • Dragon Pharmaceutical Inc • Pharmaceutical preparations • British Columbia
Agreement for Advance and Long Term Supply of ProductsDragon Pharmaceuticals Inc • September 9th, 2004 • Pharmaceutical preparations
Aurobindo (Datong) Bio-Pharma Co. Ltd. Economic & Technology Development Zone, Datong, Shanxi, China herein represented by Mr. G. P. Prasad, an Indian citizen, its Director and authorized representative
Agent AgreementAgent Agreement • September 9th, 2004 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations • Hong Kong
Allwin Biotrade, Inc., a corporation organized under the laws of British Virgin Islands with an office at East Asia Chambers, P.O. Box 901, Road Town, Tortola, British Virgin Islands
BENEFICIAL INTEREST CHANGING AGREEMENT THIS AGREEMENT is executed and effective as of this 19th day of March 2000. Between Sanhe Yianjiao Sinoway Biotech Co., Ltd. ("Sinoway") And Dragon Pharmaceutical Inc., USA WHEREAS 1. Allwin Newtech Ltd....Beneficial Interest Changing Agreement • May 15th, 2000 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.12 THIS CO-OPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT ON RECOMBINANT THROMBOPOIETIN was made between Shenzhen Kelong Chuang Jiang Shiye Co. Ltd. Hereinafter called (Party A) Nanjing Huaxin Bio-pharmaceutical Ltd. Hereinafter called (Party...Operative Research and Development Agreement • April 1st, 2002 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.22 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. TECHNOLOGY TRANSFER...Dragon Pharmaceutical Inc • March 2nd, 2005 • Pharmaceutical preparations
Manufacturing Agreement for Dry-freeze Levofloxacin InjectableDragon Pharmaceuticals Inc • September 9th, 2004 • Pharmaceutical preparations
Through friendly negotiation, party A and party B agree to enter into an agreement on manufacturing the Dry-freeze Levofloxacin Injectable as follows:
Exhibit 10.24 Portions redacted * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. TECHNOLOGY TRANSFER...Dragon Pharmaceutical Inc • March 2nd, 2005 • Pharmaceutical preparations
Agreement of Purchase and Sale of Right of Use of State-Owned-Land Article 1. This agreement is made between:Dragon Pharmaceuticals Inc • August 3rd, 2000 • Pharmaceutical preparations
TECHNOLOGY TRANSFER AGREEMENT Made this 18 day of April, 2002 BETWEENTechnology Transfer Agreement • September 9th, 2004 • Dragon Pharmaceuticals Inc • Pharmaceutical preparations
Shanxi Weiqida Pharmaceutical Co., Ltd., herein represented by Mr. Yanlin Han, hereinafter referred as “SW”, is a company registered under the laws of CHINA
